Article
Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
1 Sept 2022
Abstract excerpt
BACKGROUND: Lung adenocarcinoma (LUAD) accounts for 50% of lung cancers, with high mortality and poor prognosis. Long non-coding RNA (lncRNA) plays a vital role in the progression of tumors. Cuproptosis is a newly discovered form of cell death that is highly investigated. Therefore, in the present study, we aimed to investigate the role of cuproptosis-related lncRNA signature in clinical prognosis prediction and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
